,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1836148,5353609,Drug Gene Interaction database (DGIdb),"Methyl 2,5-dihydroxycinnamate",,CHEMBL:CHEMBL17329,https://www.dgidb.org/drugs/chembl:CHEMBL17329,,ALDH1A1,https://www.dgidb.org/genes/hgnc:402,,,216,ALDH1A1,9606,Homo sapiens (human),,,,,,,,
1,1836149,5353609,Drug Gene Interaction database (DGIdb),"Methyl 2,5-dihydroxycinnamate",,CHEMBL:CHEMBL17329,https://www.dgidb.org/drugs/chembl:CHEMBL17329,,EHMT2,https://www.dgidb.org/genes/hgnc:14129,,,10919,EHMT2,9606,Homo sapiens (human),,,,,,,,
2,1842060,5353609,Comparative Toxicogenomics Database (CTD),"Methyl 2,5-dihydroxycinnamate",C067472,"methyl 2,5-dihydroxycinnamate",https://ctdbase.org/detail.go?type=chem&acc=C067472,1437.0,CSF2,https://ctdbase.org/detail.go?type=gene&acc=1437,,,1437,CSF2,9606,Homo sapiens (human),"CSF2 protein affects the susceptibility to [nitroblue tetrazolium co-treated with methyl 2,5-dihydroxycinnamate]",,,PMID:8471626,https://www.ncbi.nlm.nih.gov/pubmed/8471626,8471626.0,,
